B25.2
Cytomegaloviral pancreatitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytomegaloviral pancreatitis is an inflammation of the pancreas caused by an infection with the cytomegalovirus (CMV). This condition predominantly affects individuals with weakened immune systems, such as those who have undergone organ transplants, are receiving immunosuppressive therapy, or have certain chronic illnesses. Recognizing the signs and understanding the nature of this disease can help in early diagnosis and management. However, it is essential to seek medical advice for appropriate treatment tailored to individual circumstances.
Causes & Symptoms
Clinical Causes: Reactivation of latent cytomegalovirus infection in immunocompromised individuals Primary CMV infection in people with weakened immune systems Use of immunosuppressive medications post-organ transplantation Advanced HIV/AIDS infection Congenital CMV infection passed from mother to baby
Key Symptoms: Abdominal pain, particularly in the upper abdomen Nausea and vomiting Fever and chills Loss of appetite Fatigue and general malaise Jaundice (yellowing of the skin and eyes) in some cases Elevated pancreatic enzymes in blood tests
Diagnostic & Treatment
Diagnosis Path: Diagnosing cytomegaloviral pancreatitis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests to detect CMV DNA or antibodies can indicate active or recent infection. Imaging techniques like ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) help visualize pancreatic inflammation. In some cases, tissue biopsies may be necessary to confirm the diagnosis and rule out other causes of pancreatitis.
Treatment Protocols: Treatment strategies primarily focus on controlling the underlying CMV infection and managing pancreatic inflammation. Antiviral medications such as ganciclovir or valganciclovir are commonly prescribed to inhibit CMV replication. Supportive care includes pain management, hydration, and nutritional support. Addressing the immune status of the patient, such as adjusting immunosuppressive therapy under medical supervision, is also crucial. Recovery varies depending on the severity of the infection and the overall health of the individual.
Clinical Advice & FAQs
Billing Guidance
Is B25.2 a billable ICD-10 code?
Yes, B25.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B25.2?
Clinical documentation must specify the nature of Cytomegaloviral pancreatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
